| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/10/2008 | CA2665380A1 Treatment of insulin resistance and disorders associated therewith |
| 04/10/2008 | CA2665141A1 Composition comprising crustacean gastrolith components and its use |
| 04/10/2008 | CA2665037A1 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 04/10/2008 | CA2664842A1 Arginine derivatives with np-i antagonistic activity |
| 04/10/2008 | CA2664413A1 Treatment for non-alcoholic-steatohepatitis |
| 04/10/2008 | CA2664004A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 04/09/2008 | EP1908765A1 Thienopyrimidine derivative |
| 04/09/2008 | EP1908757A1 Choline salt crystal of azulene compound |
| 04/09/2008 | EP1908753A1 Novel heterocyclidene acetamide derivative |
| 04/09/2008 | EP1908492A1 Metabotropic glutamate receptor activator |
| 04/09/2008 | EP1908480A1 Interferon- alpha regulator |
| 04/09/2008 | EP1908474A2 Physiologically active compositions of basidiomycotina and araliaceae extracts |
| 04/09/2008 | EP1907569A1 Genetic variants in the tcf7l2 gene as diagnostic markers for risk of type 2 diabetes mellitus |
| 04/09/2008 | EP1907398A1 Therapeutic agents |
| 04/09/2008 | EP1907387A1 An oxime derivative and preparations thereof |
| 04/09/2008 | EP1907386A1 Amino acid salts of rosiglitazone |
| 04/09/2008 | EP1907383A1 Gpcr agonists |
| 04/09/2008 | EP1907370A2 Novel 1,4-benzothiazepine-1,1-dioxide derivative having improved properties, method for the production thereof, medicaments containing said compound, and use thereof |
| 04/09/2008 | EP1907361A1 Amide derivatives as kinase inhibitors |
| 04/09/2008 | EP1907357A1 Aniline sulfonamide derivatives and their uses |
| 04/09/2008 | EP1907005A1 Compositions for affecting weight loss |
| 04/09/2008 | EP1906991A2 Use of glp-1 receptor agonists and/or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i, diabetes type ii and impaired pancreatic beta-cell function |
| 04/09/2008 | EP1906983A2 Cynara scolymus extracts, the use thereof ans formulations containing them |
| 04/09/2008 | EP1824501A4 Protein hydrolysate with antidiabetic effect |
| 04/09/2008 | EP1605957B1 The use of lupin conglutin for the treatment of type ii diabetes |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1429757B1 Crystalline forms of fluvastatin sodium |
| 04/09/2008 | EP1414444B1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 04/09/2008 | EP1173767B1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 04/09/2008 | EP1140964B1 Connective tissue growth factor (ctgf) fragment |
| 04/09/2008 | EP1036175B1 Human brain derived kcnq2 potassium channel |
| 04/09/2008 | CN101160309A Novel imidazo [1, 5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 04/09/2008 | CN101160296A 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2, 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 04/09/2008 | CN101160289A Pyridazine derivatives and their use as therapeutic agents |
| 04/09/2008 | CN101157725A Preparation method of human insulin analogue and usage thereof |
| 04/09/2008 | CN101157710A Method for preparing iron supplementary carboxymethyl Chitosan oligosaccharide ferrous |
| 04/09/2008 | CN101157692A Berberinc derivatives, preparation method and medicinal composition and usage thereof |
| 04/09/2008 | CN101156951A Method and composition for eliminating odors in ion exchange resins |
| 04/09/2008 | CN101156947A Ginseng source peptide albumen, its preparing method and application |
| 04/09/2008 | CN101156946A Application of antihypelipidemic medicine, hydrochloric acid racemic anisodamine, vitamine B**, nerve growth factor in the preparation of combination medicine for treating diabetes |
| 04/09/2008 | CN101156936A An administer orally mixed nucleus glycosides as well as its preparing technics |
| 04/09/2008 | CN101156915A Traditional Chinese medicine valid target composition of preventing and treating diabetes as well as preparation and application |
| 04/09/2008 | CN101156908A Alpha-glucosidase inhibitor- potentilla anserine extract as well as extracting method |
| 04/09/2008 | CN101156891A Combustion grease slimming cream |
| 04/09/2008 | CN101156883A Stevia rebaudian valid target as well as its activity and application |
| 04/09/2008 | CN101156878A Milk cow organism grape-sugar calcium |
| 04/09/2008 | CN101156869A A medicine for treating hyperphosphatemia disease and iron deficiency anemia disease |
| 04/09/2008 | CN101156867A Tea polyphenol pellicle and method for making same |
| 04/09/2008 | CN101156862A A lecithin vitamine E mastication piece and method for making same |
| 04/09/2008 | CN101156857A A composite vitamine and its preparation method as well as application |
| 04/09/2008 | CN101156853A Hydrochloric acid glitazone dispersion piece and its preparation method |
| 04/09/2008 | CN101156847A Usage of purplish plastocyanin as insulin sensitization agent as well as its preparation |
| 04/09/2008 | CN101156842A Pharmaceutical preparation containing arginine glutamic acid |
| 04/09/2008 | CN101156837A A method for preparing compound recipe amino acid vitamin micro pill capsule |
| 04/09/2008 | CN101156689A A functional food for diabetic |
| 04/09/2008 | CN101156680A Food composition of nourishing blood anti-senescence and method for producing same |
| 04/09/2008 | CN100379850C Preparation method of ganoderma biological activity multivitamin intesifying agent |
| 04/09/2008 | CN100379735C 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-1j]quinoline derivatives as antipsychotic and antiobesity agents |
| 04/09/2008 | CN100379734C Azaindoles |
| 04/09/2008 | CN100379448C 蛋白酶抑制剂 Protease inhibitors |
| 04/09/2008 | CN100379441C Sugar downbearing network vessel freeing Chinese medicinal preparation |
| 04/09/2008 | CN100379433C Method of treating diabetes by using plant argyrolobium roseum extract |
| 04/09/2008 | CN100379430C Sturgeon chondroition capsule and instant granula preparation method therefor |
| 04/09/2008 | CN100379426C Pyrimidine nucleoside and pharmacy usage of pyrimidine nucleotide precursor |
| 04/09/2008 | CN100379412C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia |
| 04/09/2008 | CN100379410C Therapeutic drug for diabetes |
| 04/08/2008 | US7355093 Transgenic rodent for use as tools in identifying modulator for treatment of diabetes, hypertension, cardiovascular and bone disorders |
| 04/08/2008 | US7355069 2-[2-(4-{2-[ethyl(2-fluorobenzyl)amino]-2-oxoethoxy}phenyl)ethoxy]benzoic acid; peroxisome proliferator-activated receptors alfa agonist; antidiabetic, hypotensive agent; obesity, elevated VLDL (Very Low Density Lipoproteins) and reduced HDL (High Density Lipoprotein) concentrations |
| 04/08/2008 | US7355054 Indole derivatives |
| 04/08/2008 | US7355052 Melanocortin receptors; analgesivs; antiinflammatory agents; eating disorders; psycological disorders; anxiolytic agents; antidepressants; anticancer agents; aids; antiarthritic agents |
| 04/08/2008 | US7355024 Regulatory sequences for modulation of INGAP expression and reporter constructs |
| 04/08/2008 | US7354953 Administering Cr3O(carboxylate)6(ligand)3]+ (3)wherein carboxylate is a C2-C5 alkyl carboxylate and wherein the ligand is a ligand that (i) renders the chromium complex insoluble or only slightly soluble in water and (ii) is acid labile; diabetes |
| 04/08/2008 | US7354941 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes |
| 04/08/2008 | US7354934 N1-(1H-Benzimidazol-2-ylmethyl)-N1-(5,6,7,8-tetrahydro-quinolin-8-yl)-butane-1,4-diamine; fusin and chemokine receptor antagonist; increase progenitor and stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 04/08/2008 | US7354929 6-benzyl-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-2,6-dihydropyrazolo[3,4-c]pyridin-7-one; eating and psychological disorders; obesity, alcoholism |
| 04/08/2008 | US7354919 Isoxazole compositions useful as inhibitors of ERK |
| 04/08/2008 | US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists |
| 04/08/2008 | US7354765 Soybean plants with enhanced expression of daidzein and genistein; for use in improving nutrient quality of foods |
| 04/08/2008 | US7354738 isolated polypeptide modulates activity of nuclear receptor/ nuclear respiratory factor, brown adipose cell determination/differentiation, mitochondrial activity, biogenesis, fatty acid oxidation |
| 04/08/2008 | US7354736 Intracellular caspase inhibitory polypeptide for use in treatment and prevention of cell proliferative, nervous system and autoimmune disorders |
| 04/08/2008 | US7354724 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same |
| 04/08/2008 | US7354606 touchi plant extract and phaseolamin mixture for limiting the absorption of carbohydrates contained in a foodstuff, for promoting weight loss in an individual; nutraceuticals |
| 04/08/2008 | US7354576 Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase |
| 04/08/2008 | CA2372962C Novel interleukin-1 and tumor necrosis factor-.alpha. modulators, syntheses of said modulators and methods of using said modulators |
| 04/08/2008 | CA2305764C Bile acid salts of metals with physiological action and the use thereof in therapy |
| 04/08/2008 | CA2141953C Pharmaceutical formulations of interleukin-1 inhibitors |
| 04/06/2008 | CA2562821A1 Composition and method for raising blood glucose level |
| 04/03/2008 | WO2008039882A1 A combination of niacin and a prostaglandin d2 receptor antagonist |
| 04/03/2008 | WO2008039754A1 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 04/03/2008 | WO2008039094A1 Weight reducing composition |
| 04/03/2008 | WO2008039023A1 Heteroaryl-pyrazole derivatives as cannabinoid cb1 receptor antagonists |
| 04/03/2008 | WO2008038768A1 Compound having bicyclic pyrimidine structure and pharmaceutical composition comprising the compound |
| 04/03/2008 | WO2008038712A1 Therapeutic/prophylactic agent for metabolic syndrome |
| 04/03/2008 | WO2008038705A1 Glycation inhibitor |
| 04/03/2008 | WO2008038692A1 Diaryl ketimine derivative |
| 04/03/2008 | WO2008038394A1 Musclin receptor and use thereof |
| 04/03/2008 | WO2008038305A2 Therapeutical formulation comprising a thiazolidinedione and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038304A2 Therapeutical formulation comprising an alpha-glucosidase inhibitor and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038303A2 Therapeutic formulation comprising a sulfonylurea, a thiazolidinedione and a nitric oxide scavenger. |
| 04/03/2008 | WO2008038302A2 Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger. |